Best Peptides for Energy: What the Research Actually Shows

Peptides most often studied for energy target three pathways: mitochondrial ATP production, growth hormone signaling that affects sleep and recovery, and immune or oxidative stress balance. Human evidence is strongest for NAD+ precursor and glutathione studies; many other longevity peptides remain investigational and should be discussed with a licensed clinician, not bought as research chemicals online 1 2 12.

How can peptides affect energy levels?

Peptides can affect energy only if they change a pathway that matters for fatigue, such as ATP production, sleep quality, muscle recovery, inflammation, or oxidative stress. The key point is that a peptide does not “give energy” like caffeine; it may support slower biology over weeks, depending on the compound, the person, and the cause of fatigue 1 2 14.

What peptides are and how they signal

Peptides are short chains of amino acids. Some act like tiny messages that bind to receptors on cells. Others, like glutathione, are small peptide-like molecules the body already uses for antioxidant balance 2.

NAD+ (nicotinamide adenine dinucleotide) is not a peptide, but it is often discussed with longevity peptides because it helps mitochondria move electrons during energy metabolism. Human trials of NAD+ precursors such as nicotinamide riboside show that NAD+ metabolism can be changed in people, but symptom benefits are less certain 1.

The three pathways that matter: mitochondria, growth hormone, and inflammation

• Mitochondrial ATP production: mitochondria make most cellular ATP, the energy currency cells use. NAD+ and MOTS-c are discussed because they relate to mitochondrial metabolism and stress signaling 1 3.
• Growth hormone signaling: sermorelin (a GHRH analog), tesamorelin (Egrifta, a GHRH analog), CJC-1295, ipamorelin, and GHRP-2 sit in or near the growth hormone secretagogue drug class. This pathway can affect sleep architecture, lean mass, fat distribution, and recovery markers, while also raising risks like fluid retention, joint symptoms, and glucose changes 6 7 8.
• Inflammation and oxidative stress: glutathione and thymosin alpha-1 (Zadaxin in some countries) are discussed because oxidative stress and immune activation can make people feel drained. Immune-active compounds also need caution in autoimmune disease, transplant care, cancer care, pregnancy, and complex medication use 2 9.

Which peptides are most studied for energy and fatigue?

Energy peptides are not one category. The best way to compare them is by mechanism, human evidence, realistic expectations, side effects, and legal status rather than by a simple ranked list; for this group, the evidence ranges from human randomized trials to mostly animal data 1 3 12.

NAD+ and NAD+ precursors (mitochondrial ATP)

NAD+ means nicotinamide adenine dinucleotide, a cofactor used by mitochondria in energy metabolism and by enzymes involved in DNA repair and cellular stress responses. In a randomized crossover trial, Martens et al. studied nicotinamide riboside in older adults and found it increased NAD+ metabolites and was generally well tolerated over the study period; individual results vary 1.

The realistic expectation is not an instant stimulant effect. NAD+ support is best understood as a mitochondrial-metabolism strategy, and human symptom data for fatigue are still mixed. Side effects reported in NAD+ precursor research can include nausea, flushing, headache, stomach upset, and lab-marker changes; people with liver disease, kidney disease, pregnancy, active cancer, or complex medication lists need clinician review 1 14.

At Chia, we offer NAD+ as an injection with plans currently starting from $199/mo and as a nasal spray with plans currently starting from $129/mo. Our providers review each patient’s health history online and prescribe only when clinically appropriate.

MOTS-c (mitochondrial-derived peptide)

MOTS-c is a mitochondrial-derived peptide encoded within mitochondrial DNA. Lee et al. described MOTS-c as a peptide that can move to the nucleus during metabolic stress and influence stress-response genes, which is why it attracts interest for stamina and metabolic health 3.

For energy, the honest answer is that human evidence is still early. The mechanism is interesting, but it does not prove that MOTS-c improves chronic fatigue in patients. Safety data are limited, so risks include injection-site reactions, unknown long-term endocrine or metabolic effects, and major quality concerns if obtained from unlicensed research-chemical vendors 3 12.

Sermorelin and tesamorelin (GHRH analogs)

Sermorelin is a GHRH analog, meaning it mimics growth hormone-releasing hormone and signals the pituitary gland to release growth hormone in a more upstream way. It is discussed for energy because sleep, recovery, body composition, and growth hormone signaling can overlap, but fatigue-specific evidence is limited 7.

At Chia, we offer sermorelin as an injection with plans currently starting from $199/mo, plus nasal spray and tablets. Provider oversight matters because growth hormone-axis therapy can cause fluid retention, joint pain, numbness or tingling, headache, and glucose changes, and it may not be appropriate with active cancer, uncontrolled diabetes, pregnancy, severe untreated sleep apnea, or certain pituitary conditions 6 7.

Tesamorelin, sold as Egrifta SV, is also a GHRH analog. Its FDA label is for reducing excess abdominal fat in adults with HIV-associated lipodystrophy, and label warnings include hypersensitivity reactions, fluid retention, glucose intolerance or diabetes risk, and malignancy-related precautions 6. That makes tesamorelin a clear example of why an FDA-reviewed drug can still have a narrow indication and real risks.

CJC-1295 plus ipamorelin (growth hormone secretagogues)

CJC-1295 is a long-acting GHRH analog, while ipamorelin is a ghrelin-receptor agonist and growth hormone secretagogue. They are often discussed together because one signal acts through GHRH biology and the other through ghrelin-receptor biology, creating a stronger growth hormone-axis signal in research settings 8.

The practical question is whether higher growth hormone markers translate into better daily energy. That has not been proven for chronic fatigue. Side effects can include water retention, joint discomfort, tingling, headache, appetite changes, glucose changes, and pituitary-axis concerns; this is why clinician monitoring is more important than chasing a “stack” from a vial seller 6 8 12.

GHRP-2 (growth hormone secretagogue drug class)

GHRP-2 is a growth hormone-releasing peptide and part of the growth hormone secretagogue drug class. Human endocrine studies show that this drug class can stimulate growth hormone release, which explains the interest in sleep, recovery, and body composition rather than a direct “energy” effect 8.

GHRP-2 can also affect appetite and glucose-related signaling. Possible risks include hunger, water retention, glucose changes, headache, and endocrine effects. It is a poor fit for self-treatment because fatigue can come from conditions like anemia, hypothyroidism, sleep apnea, depression, or medication side effects that need standard care first 8 14.

Glutathione (antioxidant support)

Glutathione is a tripeptide antioxidant made from glutamate, cysteine, and glycine. It helps cells manage oxidative stress, which is one reason it is discussed for energy, recovery, and resilience even though fatigue is more complex than oxidative stress alone 2.

In a controlled human study, Richie et al. found that oral glutathione supplementation increased body glutathione stores over time; individual results vary 2. Realistic expectations should stay modest: raising a biomarker is not the same as proving better stamina. Side effects may include bloating, cramps, allergic reactions, and medication interactions, especially for people in cancer care, immune therapy, or chronic lung disease treatment 2.

At Chia, we offer glutathione as an injection with plans currently starting from $199/mo and as a nasal spray. Our providers review health history, medications, and goals before deciding whether treatment fits.

Thymosin alpha-1 (immune-driven fatigue)

Thymosin alpha-1, known as Zadaxin in some countries, is an immune-modulating peptide. It has been studied as an adjunct in certain infections and immune conditions, which is why people ask about it after viral illness or with immune-driven fatigue 9.

The evidence does not make thymosin alpha-1 a proven fatigue treatment. A meta-analysis in sepsis research suggested immune and clinical signals in a very different hospitalized population, so those findings cannot be assumed to apply to outpatient fatigue 9. Risks may include injection-site reactions, fever, aches, immune flares, and special concern in autoimmune disease, transplant care, cancer care, pregnancy, or immune-suppressing medicine use 9.

BPC-157 and TB-500 (recovery-related energy)

BPC-157 is a synthetic peptide studied mostly in animal models for tissue-injury and gut-barrier pathways. TB-500 commonly refers to thymosin beta-4 fragments, a group discussed for cell migration, tissue remodeling, and repair signaling 10 11.

People connect these peptides with energy because pain, injury, poor sleep, and overtraining can feel like fatigue. But fatigue-specific human evidence is weak. Possible risks include injection reactions, immune effects, unknown cancer-related risks, unclear long-term safety, and product-quality problems when purchased outside licensed pharmacy channels 10 11 12.

Epithalon (sleep and circadian regulation)

Epithalon, also called epitalon, is a synthetic tetrapeptide discussed in aging, telomere, pineal, and circadian biology. The energy theory is indirect: better sleep timing may support daytime alertness 12.

For this one, the honest answer is that strong U.S.-relevant human evidence for fatigue is lacking. Risks are not well mapped and may include injection-site reactions, unknown endocrine or immune effects, and uncertain long-term safety. Sleep-related fatigue still needs a workup for insomnia, sleep apnea, alcohol use, shift work, depression, pain, and medication timing 12 14.

AOD9604 and 5-Amino-1MQ (metabolic energy claims)

AOD9604 is a modified fragment related to human growth hormone. In obesity research, it was studied for metabolic effects, but it did not become an FDA-approved energy or weight-loss drug 5.

5-Amino-1MQ is not a peptide; it is a small molecule often discussed near peptides because it targets NNMT, an enzyme involved in cellular metabolism. Human fatigue evidence is limited. For both AOD9604 and 5-Amino-1MQ, realistic expectations should be cautious, and risks include uncertain long-term metabolic effects, drug-condition interactions, and quality concerns from non-prescription sources 5 12.

What peptide is best for chronic fatigue?

There is no single best peptide for chronic fatigue, because chronic fatigue is a symptom, not one diagnosis. The right starting point is a clinical workup for common causes, often before any peptide is considered; fatigue lasting weeks to months deserves medical review 14.

When fatigue is mitochondrial

Mitochondrial-pattern fatigue may show up as exercise intolerance, post-exertional crashes, or fatigue tied to metabolic disease. NAD+ support has more human biomarker evidence than MOTS-c, while MOTS-c remains more mechanistic and early-stage 1 3.

Even then, mitochondrial fatigue overlaps with anemia, heart disease, sleep disorders, post-viral syndromes, medication effects, and endocrine disease. Side effects and contraindications matter: NAD+ products can cause GI symptoms or flushing, while MOTS-c has limited human safety data 1 3 14.

When fatigue is hormonal

Hormonal-pattern fatigue may come with poor sleep, low libido, body composition change, hot flashes, low mood, or reduced exercise recovery. Clinicians often check thyroid, sex hormones, diabetes markers, cortisol context, medications, and sleep quality before focusing on growth hormone-axis peptides 6 14.

Sermorelin, tesamorelin, CJC-1295, ipamorelin, and GHRP-2 may influence growth hormone signaling, but they can also affect fluid balance, joints, nerves, glucose, and pituitary-axis biology. They need careful review in people with uncontrolled diabetes, active cancer, pregnancy, significant swelling, severe untreated sleep apnea, or pituitary disease 6 8.

When fatigue is inflammatory or post-viral

Inflammatory or post-viral fatigue can include body aches, crashes after activity, swollen glands, feverish feelings, or new symptoms after infection. Immune-active compounds such as thymosin alpha-1 are sometimes discussed, but evidence from sepsis, hepatitis, or other immune studies should not be stretched into a fatigue promise 9.

This is also the group where caution matters most. Autoimmune disease, transplant history, cancer therapy, immune-suppressing drugs, pregnancy, and ongoing infection can change the risk-benefit picture. A clinician should look for treatable causes and red flags before considering immune-modulating therapy 9 14.

What peptides may support motivation and mental energy?

Motivation and mental energy are different from physical stamina. Selank, Semax, and growth hormone-axis peptides are discussed online for brain fog or drive, but the evidence is limited and does not replace screening for depression, anxiety, ADHD, insomnia, sleep apnea, substance use, medication effects, or thyroid disease 12 14.

Selank and Semax: what the research says

Selank is a synthetic regulatory peptide related to tuftsin pathways and studied mainly outside the U.S. for stress and anxiety-related biology. Semax is a synthetic ACTH-derived peptide studied mostly outside the U.S. for nervous-system and cognition-related pathways 12.

For motivation, the human evidence base is not strong enough to call either a proven option. Possible risks include nasal irritation if used intranasally, headache, mood changes, sleep changes, and interactions with psychiatric medicines. Product identity and sterility are also major concerns when these are bought outside licensed care 12.

Growth hormone peptides and sleep-driven mental clarity

Some people feel mentally sharper when sleep and recovery improve, which is why growth hormone secretagogues show up in “mental energy” discussions. The mechanism is indirect: growth hormone signaling may affect sleep depth, tissue repair, and body composition markers, not dopamine-like motivation 6 8.

The trade-off is that the same pathway can cause swelling, joint pain, tingling, carpal tunnel-type symptoms, glucose changes, and headaches. If brain fog is driven by sleep apnea, depression, low iron, thyroid disease, alcohol, or medication timing, a growth hormone-axis peptide may miss the real cause 6 8 14.

How do peptides for energy compare?

Peptides for energy compare best by pathway and evidence, not by popularity. The table below uses 5 practical columns: mechanism, human evidence, realistic expectation, key risks, and current status 1 6 12.

Are energy peptides safe?

Energy peptides are not automatically safe just because many are small chains of amino acids. Safety depends on the compound, route, sterility, medical history, drug interactions, and whether the medication comes through a licensed provider and a licensed pharmacy rather than a no-prescription research-chemical seller 12 13.

• Injection risks: pain, redness, swelling, infection, sterile abscess, and mixing errors can happen with injectable products 12.
• Hormone-axis risks: growth hormone secretagogues may cause fluid retention, joint pain, numbness or tingling, carpal tunnel-type symptoms, headaches, and glucose changes 6 8.
• Immune risks: thymosin alpha-1 and similar immune-active compounds may be inappropriate for people with autoimmune disease, transplant history, cancer treatment, pregnancy, or immune-suppressing medicines 9.
• Metabolic risks: NAD+ products, MOTS-c, AOD9604, and 5-Amino-1MQ are discussed for metabolism, but people with liver disease, kidney disease, diabetes, pregnancy, cancer history, or complex medications need clinician review 1 3 5.
• Quality risks: research chemicals, gray-market peptide vials, and non-prescribed injections may have the wrong ingredient, wrong strength, contamination, or poor storage 12 13.

What is the legal and regulatory status of these peptides in the U.S.?

FDA status affects labeling, evidence review, manufacturing, and compounding rules. A practical way to think about the U.S. landscape is this: tesamorelin has a narrow FDA-approved indication, some treatments may be compounded for an individual patient when legally allowed, and many internet-marketed peptides sit outside appropriate prescription care 6 12 13.

FDA-approved vs research-only peptides

Tesamorelin’s FDA label is specific: it is indicated for reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. The same label lists important risks, including hypersensitivity, fluid retention, glucose intolerance, and malignancy-related precautions 6.

BPC-157, TB-500 or thymosin beta-4 fragments, CJC-1295, ipamorelin, MOTS-c, epithalon, AOD9604, 5-Amino-1MQ, Selank, and Semax are education-only in this Chia article because they are not in our current offerings catalog. For these substances, the core safety issue for readers is avoiding no-prescription research-chemical vendors and seeking licensed medical guidance when they have symptoms 12 13 14.

503A compounded peptides and prescriber oversight

A 503A compounded medication is patient-specific and prepared by a state-licensed pharmacy or federal facility after a valid prescription. FDA states that compounded drugs are not reviewed before dispensing for safety, effectiveness, or quality, which is why the licensed-provider plus licensed-pharmacy path matters 13.

Several longevity peptides are currently under FDA review, with PCAC scheduled to discuss inclusion on the 503A Bulks List on July 23-24, 2026; this is not a guarantee of approval, availability, or future compounding status 13.

How do you get peptides for energy prescribed?

To get peptides for energy prescribed, start with a licensed clinician who can evaluate why you are tired and whether any prescription is appropriate. A real evaluation should include symptom pattern, medications, medical history, and red flags before discussing peptide therapy 14.

1. 1Describe your fatigue pattern: when it started, sleep quality, exercise tolerance, crashes after activity, mood symptoms, pain, infections, and medication changes.
2. 2Review common causes: thyroid disease, anemia, diabetes, sleep apnea, depression, vitamin deficiencies, chronic infection, autoimmune disease, and medication side effects 14.
3. 3Discuss the pathway: mitochondrial, hormonal, inflammatory, sleep-related, medication-related, or mood-related fatigue may point to different next steps.
4. 4Confirm the source: if a compounded medication is prescribed, it should come from a licensed pharmacy after a valid prescription, not a research-chemical website 13.
5. 5Plan monitoring: side effects, labs when appropriate, stop criteria, and symptoms that need urgent care should be clear before treatment starts.

How does Chia prescribe select peptides for energy-related goals?

At Chia, we offer a clinician-reviewed path for select compounded treatments patients often ask about in the energy and longevity space: NAD+, glutathione, and sermorelin. The visit is 100% online: you complete a short health questionnaire, then a licensed U.S. provider reviews it and prescribes only when clinically appropriate.

If prescribed, medications are compounded in the U.S. by state-licensed 503A compounding pharmacies and shipped to your door. Dosing is provider-guided and adjusted over time; patients can message their care team through the patient portal between visits.

We do not offer every peptide discussed in this guide. BPC-157, TB-500, MOTS-c, CJC-1295, ipamorelin, epithalon, AOD9604, 5-Amino-1MQ, Selank, and Semax are included for education, not as Chia offerings.

Frequently asked questions

Keep reading

Peptides

How to Find a Legitimate Peptide Source: A Patient’s Guide

Peptides

Peptide Cheat Sheet: Patient Reference to Common Peptides, Uses, and Dosing

Peptides

Peptide Injections: What They Are, How They Work, and What to Expect